<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37325298</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Epidemiological characteristics and trends of hand-foot-mouth disease in Shanghai, China from 2011 to 2021.</ArticleTitle><Pagination><StartPage>1162209</StartPage><MedlinePgn>1162209</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1162209</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1162209</ELocationID><Abstract><AbstractText>Hand, foot and mouth disease (HFMD) is a kind of infectious disease caused by enterovirus infection. In this study we analysed the epidemiological characteristics and time trends of HFMD, vaccination status and vaccine protection effect assessment of EV71 vaccine from 2011 to 2021 in Huangpu District, Shanghai, China. HFMD cases showed a decreasing trend year by year from 2011 to 2021, from 122 cases reported in 2012 to 7 cases in 2020, and 12 cases in 2021. Etiological diagnosis was CV-A6 in 185 cases (29.8%), CV-A16 in 209 cases (33.7%), EV-A71 in 118 cases (19.0%) and other enteroviruses in 109 cases (17.6%). After the launch of EV71 vaccine, a total of 32,221 doses of EV71 vaccine were administered between 2016 and 2021. The case-control results showed that there was no evidence to support the effectiveness of EV71 vaccine, OR (95% CI) =0.52 (0.12 ~ 2.3), <i>p</i> = 0.37. The epidemic strains have changed. Surveillance and management of HFMD remain very important in the future and EV71 vaccine is considered to be included in National Immunization Program.</AbstractText><CopyrightInformation>Copyright © 2023 Wang and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunization Program, Huangpu District Center for Disease Control and Prevention, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunization Program, Huangpu District Center for Disease Control and Prevention, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71 vaccine</Keyword><Keyword MajorTopicYN="N">HFMD</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">seasonal trend</Keyword><Keyword MajorTopicYN="N">vaccination status</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37325298</ArticleId><ArticleId IdType="pmc">PMC10267978</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1162209</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu GQ, Tan H, Li CH, Bai LQ. Incidence of hand, foot and mouth disease and effect of EV71 vaccine vaccination in Chenzhou city of Hunan province, 2013-2018. Chin J Public Health. (2020) 36:385–8. doi: 10.11847/zgggws1127276</Citation><ArticleIdList><ArticleId IdType="doi">10.11847/zgggws1127276</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu ZY, Wang X, Zhang LP, Lyu J, Li XC, Liu N, et al. . Health and economic evaluation of entervirus 71 vaccine immunization on HFMD in Minhang District of Shanghai from 2016 to 2018. Shanghai J Prev Med. (2021) 33:404–9. doi: 10.19428/j.cnki.sjpm.2021.19835</Citation><ArticleIdList><ArticleId IdType="doi">10.19428/j.cnki.sjpm.2021.19835</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, et al. . An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. (2010) 7:94. doi: 10.1186/1743-422X-7-94</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XL, Lu WW, Zhang ZY, Hao CS, Guo HJ, Zhang YT, et al. . Development of inactivated enterovirus 71 vaccine (vero cell). Chin J Viral Dis. (2018) 8:445–50.</Citation></Reference><Reference><Citation>Dong XQ, He M, Qiao MK, ShI LM, Zhang HY, Du XF. Epidemiological and pathogenic characteristics of HFMD in Nanjing, 2017-2019. J Trop Med. (2021) 21:1483–6.</Citation></Reference><Reference><Citation>Li JS, Dong XG, Qin M, Feng HR, Yang JY, Li RX, et al. . Outbreak of hand, foot, and mouth disease caused by coxsackievirus A6 in a Juku in Fengtai District, Beijing, China, 2015. Springerplus. (2016) 5:1650. doi: 10.1186/s40064-016-3307-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-016-3307-x</ArticleId><ArticleId IdType="pmc">PMC5033802</ArticleId><ArticleId IdType="pubmed">27733967</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmis BD, Downing C, Tyring S. Hand-foot-and-mouth disease caused by coxsackievirus A6 on the rise. Cutis. (2018) 102:353–6. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">30566537</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Y, Cheng ZY. Epidemiological and etiological characteristics of hand-foot-mouth disease in children aged 0-5 years in Jilin from 2011 to 2020. Matern Child Health Care China. (2021) 36:5526–9. doi: 10.19829/j.zgfybj</Citation><ArticleIdList><ArticleId IdType="doi">10.19829/j.zgfybj</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Wang T, Zhao M, Dong S, Wang S, Shi J. Spatiotemporal cluster patterns of hand, foot, and mouth disease at the province level in mainland China, 2011-2018. PLoS One (2022) 17:e0270061. doi: 10.1371/journal.pone.0270061</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270061</ArticleId><ArticleId IdType="pmc">PMC9394824</ArticleId><ArticleId IdType="pubmed">35994464</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JT, Jit M, Zheng Y, Leung K, Xing W, Yang J, et al. . Routine pediatric enterovirus 71 vaccination in China: a cost-effectiveness analysis. PLoS Med. (2016) 13:e1001975. doi: 10.1371/journal.pmed.1001975, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001975</ArticleId><ArticleId IdType="pmc">PMC4792415</ArticleId><ArticleId IdType="pubmed">26978565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Jiang SQ, Chen C, Lu Y, Wang DH, Li MX, et al. . Analysis of disease economic burden of outpatients with different types of hand, foot and mouth disease in Guangzhou. Mod Prev Med. (2022) 49:152–7.</Citation></Reference><Reference><Citation>Jin WP, Qian SS, Shen S. Progress in research on hand, foot and mouth disease-related enteroviruses and vaccines. Chin J Biol. (2021) 34:1273–83.</Citation></Reference><Reference><Citation>Xing WJ, Liao QH, Cécile V, Zhang J, Sun JL, Wu JT, et al. . Epidemiological characteristics of hand-foot-and-mouth disease in China, 2008-2012. Lancet Infect Dis. (2014) 14:308–18. doi: 10.1016/S1473-3099(13)70342-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg. (2007) 77:188–91. doi: 10.4269/ajtmh.2007.77.188, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2007.77.188</ArticleId><ArticleId IdType="pubmed">17620652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma E, Chan KC, Cheng P, Wong C, Chuang SK. The enterovirus 71 epidemic in 2008--public health implications for Hong Kong. Int J Infect Dis. (2010) 14:e775–80. doi: 10.1016/j.ijid.2010.02.2265</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.02.2265</ArticleId><ArticleId IdType="pubmed">20599410</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Goggins WB, Chan EY. Hand, foot and mouth disease in Hong Kong: a time-series analysis on its relationship with weather. PLoS One. (2016) 11:e0161006. doi: 10.1371/journal.pone.0161006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161006</ArticleId><ArticleId IdType="pmc">PMC4988669</ArticleId><ArticleId IdType="pubmed">27532865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhou J, Xie G, Zheng S, Lou B, Chen Y, et al. . The epidemiological and clinical characteristics of hand, foot, and mouth disease in Hangzhou, China, 2016 to 2018. Clin Pediatr (Phila). (2020) 59:656–62. doi: 10.1177/0009922820910822, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0009922820910822</ArticleId><ArticleId IdType="pubmed">32146823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singap. (2009) 38:106–12. doi: 10.47102/annals-acadmedsg.V38N2p106</Citation><ArticleIdList><ArticleId IdType="doi">10.47102/annals-acadmedsg.V38N2p106</ArticleId><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yan XL, Xie ZX, Huang SH, Xu CY. Etiological characteristics influencing factors for hand, foot and mouth disease in children from 2012 to 2017. Chin J Nosocomiol. (2019) 29:2037–40.</Citation></Reference><Reference><Citation>Wang SM, Ho TS, Lin HC, Lei HY, Wang JR, Liu CC. Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity. Eur J Clin Microbiol Infect Dis. (2012) 31:1219–24. doi: 10.1007/s10096-011-1432-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-011-1432-6</ArticleId><ArticleId IdType="pubmed">21983920</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, Chu K, et al. . Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One. (2012) 7:e37206. doi: 10.1371/journal.pone.0037206, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037206</ArticleId><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, et al. . Emerging enteroviruses causing hand, foot and mouth disease, China, 2010-2016. Emerg Infect Dis. (2018) 24:1902–6. doi: 10.3201/eid2410.171953, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2410.171953</ArticleId><ArticleId IdType="pmc">PMC6154135</ArticleId><ArticleId IdType="pubmed">30226172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti-Infect Ther. (2015) 13:1061–71. doi: 10.1586/14787210.2015.1058156, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, et al. . Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. (2013) 381:2024–32. doi: 10.1016/S0140-6736(13)61049-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, et al. . Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. (2014) 370:818–28. doi: 10.1056/NEJMoa1304923, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. . An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. (2014) 370:829–37. doi: 10.1056/NEJMoa1303224, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhou Y, Cheng Y, Wu P, Zhou C, Cui P, et al. . Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017–18: a test-negative case-control study. Lancet Child Adolesc Health. (2019) 3:697–704. doi: 10.1016/S2352-4642(19)30185-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30185-3</ArticleId><ArticleId IdType="pmc">PMC8713082</ArticleId><ArticleId IdType="pubmed">31375313</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Zeng G, Chu K, Zhang J, Han W, Zhang Y, et al. . Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: a further observation. Hum Vaccin Immunother. (2018) 14:1517–23. doi: 10.1080/21645515.2018.1442997, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1442997</ArticleId><ArticleId IdType="pmc">PMC6037439</ArticleId><ArticleId IdType="pubmed">29482422</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, An Z, Huo D, Jia L, Li J, Yang Y, et al. . Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China. Hum Vaccin Immunother. (2019) 15:1183–90. doi: 10.1080/21645515.2019.1581539, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1581539</ArticleId><ArticleId IdType="pmc">PMC6605830</ArticleId><ArticleId IdType="pubmed">30779680</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng XD, Tong Y, Wei ZN, Wang L, Mai JY, Wu Y, et al. . Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China. Sci Rep. (2020) 10:20909. doi: 10.1038/s41598-020-77768-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77768-7</ArticleId><ArticleId IdType="pmc">PMC7708472</ArticleId><ArticleId IdType="pubmed">33262488</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Mauleekoonphairoj J, Linsuwanon P, Suwannakarn K, Chieochansin T, Korkong S, et al. . Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One. (2014) 9:e98888. doi: 10.1371/journal.pone.0098888, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098888</ArticleId><ArticleId IdType="pmc">PMC4041783</ArticleId><ArticleId IdType="pubmed">24887237</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoa-Tran TN, Dao ATH, Nguyen AT, Kataoka C, Takemura T, Pham CH, et al. . Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: essential information for rational vaccine design. Vaccine. (2020) 38:8273–85. doi: 10.1016/j.vaccine.2020.11.031, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.11.031</ArticleId><ArticleId IdType="pubmed">33223308</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol. (2016) 205:397–407. doi: 10.1007/s00430-016-0465-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang CY, Liu CC. Recent development of enterovirus a vaccine candidates for the prevention of hand, foot, and mouth disease. Expert Rev Vaccines. (2018) 17:819–31. doi: 10.1080/14760584.2018.1510326, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1510326</ArticleId><ArticleId IdType="pubmed">30095317</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S, Liao Y, Jiang G, Wang L, Zhao H, Yu L, et al. . Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally. Vaccine. (2021) 39:596–604. doi: 10.1016/j.vaccine.2020.11.070, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.11.070</ArticleId><ArticleId IdType="pubmed">33342637</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Fuchs J, Das SC, Partidos CD, Osorio JE. Efficacy of a trivalent hand, foot, and mouth disease vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in mice. Viruses. (2015) 7:5919–32. doi: 10.3390/v7112916, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112916</ArticleId><ArticleId IdType="pmc">PMC4664989</ArticleId><ArticleId IdType="pubmed">26593938</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>